C C Lucas|M E Dolan - JoVE Visualize

Showing results (81-90 of 135) with videos related to

Pageof 14

Sort By:

Cancer Research|September 1, 1994

Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenograftsM E Dolan, M J Fleig, B G Feuerstein, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000

Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patientsA B Benson, O I Olopade, M J Ratain, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000

Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancerR L Schilsky, M E Dolan, D Bertucci, et al.

Biochemical Pharmacology|June 20, 1998

O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterasesM E Dolan, S K Roy, B J Garbiras, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agentE Gupta, O I Olopade, M J Ratain, et al.

Cancer Research|July 1, 1995

Activity of temozolomide in the treatment of central nervous system tumor xenograftsH S Friedman, M E Dolan, A E Pegg, et al.

SLAS Discovery : Advancing Life Sciences R & D|January 26, 2024

Covalent hits and where to find themSimon C C Lucas, J Henry Blackwell, Sarah H Hewitt, et al.

Anti-Cancer Drugs|July 11, 1998

Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agentsM E Dolan, B Frydman, C B Thompson, et al.

Journal of the National Cancer Institute|December 26, 1992

Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiformeH S Friedman, M E Dolan, R C Moschel, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancerR A Humerickhouse, M E Dolan, D J Haraf, et al.

Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:

Pageof 14

Cancer Research|September 1, 1994

Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenograftsM E Dolan, M J Fleig, B G Feuerstein, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000

Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patientsA B Benson, O I Olopade, M J Ratain, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000

Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancerR L Schilsky, M E Dolan, D Bertucci, et al.

Biochemical Pharmacology|June 20, 1998

O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterasesM E Dolan, S K Roy, B J Garbiras, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agentE Gupta, O I Olopade, M J Ratain, et al.

Cancer Research|July 1, 1995

Activity of temozolomide in the treatment of central nervous system tumor xenograftsH S Friedman, M E Dolan, A E Pegg, et al.

SLAS Discovery : Advancing Life Sciences R & D|January 26, 2024

Covalent hits and where to find themSimon C C Lucas, J Henry Blackwell, Sarah H Hewitt, et al.

Anti-Cancer Drugs|July 11, 1998

Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agentsM E Dolan, B Frydman, C B Thompson, et al.

Journal of the National Cancer Institute|December 26, 1992

Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiformeH S Friedman, M E Dolan, R C Moschel, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancerR A Humerickhouse, M E Dolan, D J Haraf, et al.

Pageof 14